Ching W. Chong,Robert Kuehl,Heow Tan,Harisha Atluri
申请号：
US16846064
公开号：
US20200237673A1
申请日:
2020.04.10
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Described herein are pharmaceutical formulations of Bruton's tyrosine kinase (Btk) inhibitor 1-((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one. Also disclosed are methods of using the Btk inhibitor, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.
